Parallax Volatility Advisers’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-50,000
Closed -$350K 1824
2025
Q4
$350K Sell
50,000
-75,000
-60% -$587K ﹤0.01% 1288
2025
Q3
$966K Hold
125,000
﹤0.01% 1118
2025
Q2
$1.09M Buy
125,000
+50,000
+67% +$362K ﹤0.01% 1033
2025
Q1
$597K Buy
+75,000
New +$759K ﹤0.01% 1154
2024
Q1
Sell
-5,600
Closed -$121K 2342
2023
Q4
$121K Sell
5,600
-9,100
-62% -$168K ﹤0.01% 1852
2023
Q3
$273K Buy
14,700
+800
+6% +$18.7K ﹤0.01% 1746
2023
Q2
$352K Buy
13,900
+12,500
+893% +$315K ﹤0.01% 1762
2023
Q1
$36.3K Sell
1,400
-44,100
-97% -$1.18M ﹤0.01% 2251
2022
Q4
$1.08M Sell
45,500
-36,700
-45% -$990K ﹤0.01% 1629
2022
Q3
$2.08M Sell
82,200
-134,500
-62% -$4.72M ﹤0.01% 1410
2022
Q2
$7.2M Sell
216,700
-147,700
-41% -$6.27M 0.01% 843
2022
Q1
$26.3M Sell
364,400
-653,500
-64% -$47.1M 0.01% 417
2021
Q4
$93.5M Buy
1,017,900
+101,300
+11% +$12.1M 0.11% 129
2021
Q3
$116M Buy
916,600
+110,200
+14% +$16M 0.11% 134
2021
Q2
$134M Buy
806,400
+680,900
+543% +$110M 0.18% 81
2021
Q1
$22.8M Buy
125,500
+57,600
+85% +$13.4M 0.05% 258
2020
Q4
$13.6M Sell
67,900
-5,000
-7% -$1.02M 0.01% 636
2020
Q3
$16M Sell
72,900
-87,000
-54% -$18.4M 0.01% 802
2020
Q2
$30.5M Buy
159,900
+148,900
+1,354% +$26.1M 0.04% 389
2020
Q1
$1.71M Buy
+11,000
New +$1.28M ﹤0.01% 1299
2018
Q1
Sell
-80,000
Closed -$2.79M 4127
2017
Q4
$2.79M Buy
+80,000
New +$2.66M ﹤0.01% 801

Other funds holding TDOC

Parallax Volatility Advisers's TDOC Position: Q4 2025 in Review

Parallax Volatility Advisers sold out of Teladoc Health (TDOC) in Q4 2025, closing a stake of 16,322 shares — an estimated $128K sold.

Parallax Volatility Advisers first reported a position in TDOC in Q4 2017 and held it in 18 quarters. The position peaked at $88.1M in Q4 2021. 344 funds tracked by Wall St. Rank hold TDOC as of Q4 2025.

  • Parallax Volatility Advisers reported no remaining Teladoc Health position as of Q4 2025 after selling out during the quarter.
  • Parallax Volatility Advisers sold 16,322 Teladoc Health shares in Q4 2025, an estimated $128K.
  • Parallax Volatility Advisers first reported a position in Teladoc Health in Q4 2017 and held it in 18 quarters.
  • Parallax Volatility Advisers's Teladoc Health position peaked at $88.1M in Q4 2021.
  • 344 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2025.

Based on Parallax Volatility Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.